| Literature DB >> 34824555 |
Anniina Heikkilä1, Lasse Lehtonen2, Jari Haukka3, Satu Havulinna4, Kristiina Junttila5.
Abstract
PURPOSE: The purpose of this study was to evaluate the validity and reliability of the Peninsula Health Fall Risk Assessment Tool (PHFRAT) in acute care in various medical specialties. The assessment has not been previously studied in acute care.Entities:
Keywords: PHFRAT; acute care; fall risk assessment; falls
Year: 2021 PMID: 34824555 PMCID: PMC8610762 DOI: 10.2147/RMHP.S332326
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Figure 1Retrospective medical data 2014–2016 for predictive validity study.
PHFRAT – Assessment Tool
| Risk Factor | Level of Factors | Risk Score |
|---|---|---|
| RECENT FALLS (To score this, complete history of falls, overleaf) | None in last 12 months | 2 |
| One or more in last 12 months | 4 | |
| One in last 3 months | 6 | |
| > 1 in last 3 months | 8 | |
| MEDICATIONS (Sedatives, Anti-Depressants, Anti-Parkinson’s, Diuretics, Anti-hypertensives, hypnotics) | Not taking any of these | 1 |
| Taking one | 2 | |
| Taking two | 3 | |
| Taking more than two | 4 | |
| PSYCHOLOGICAL (Anxiety, Depression, Cooperation, Insight or Judgement esp. re mobility) | Does not appear to have any of these | 1 |
| Appears mildly affected by one or more | 2 | |
| Appears moderately affected by one or more | 3 | |
| Appears severely affected by one or more | 4 | |
| COGNITIVE STATUS (AMTS: Hodkinson Abbreviated Mental Test Score) | AMTS 9 or 10/10 OR intact | 1 |
| AMTS 7–8 mildly impaired | 2 | |
| AMTS 5–6 mod impaired | 3 | |
| AMTS 4 or less severely impaired | 4 | |
| Low Risk: 5–11 Medium: Risk: 12–15 High Risk: 16–20 | /20 | |
The Demographic Data for Validity Study
| The PHFRAT Risk Level | Low Risk (n =1 8796) | Medium Risk (n = 3200) | High Risk (n = 704) | All Patients n = 22,700 |
|---|---|---|---|---|
| Male | 8963 (82.4) | 1563 (14.4) | 349 (3.2) | 10,875 (100) |
| Female | 9833 (83.2) | 1637 (13.8) | 355 (3.0) | 11,825 (100) |
| 18–64 | 5329 (87.5) | 631 (10.4) | 130 (2.1) | 6090 (100) |
| 65–74 | 6178 (87.0) | 758 (10.7) | 162 (2.3) | 7098 (100) |
| 74–84 | 5002 (80.7) | 992 (16.0) | 208 (3.4) | 6202 (100) |
| 85– | 2287 (69.1) | 819 (24.7) | 204 (6.2) | 3310 (100) |
| 68.8 (15.03) | 74.6 (13.64) | 75.4 (13.36) | 69.8 (15.0) | |
| Medical | 8672 (81.7) | 1627 (15.3) | 309 (2.9) | 10,608 (100) |
| Surgical | 3408 (84.7) | 500 (12.4) | 115 (2.9) | 4023 (100) |
| Obstetrics and gynecology | 583 (96.4) | 21 (3.5) | 1 (0.2) | 605 (100) |
| Ophthalmology and otolaryngology | 508 (90.1) | 49 (8.7) | 7 (1.2) | 564 (100) |
| Oncology | 1142 (92.6) | 74 (6.0) | 17 (1.4) | 1233 (100) |
| Psychiatry | 197 (67.2) | 76 (25.9) | 20 (6.8) | 293 (100) |
| Neurology | 4096 (81.6) | 724 (14.4 | 202 (4.0) | 5022 (100) |
| General medicine | 190 (54.0) | 129 (36.6) | 33 (9.4) | 352 (100) |
| All | 18,796 (82.8) | 3200 (14.1) | 704 (3.1) | 22,700 (100) |
| Somatic | 18,156 (83.8) | 2892 (13.4) | 609 (2.8) | 21,657 (100) |
| Psychiatric | 203 (65.5) | 83 (26.8) | 24 (7.7) | 310 (100) |
| Emergency | 437 (59.6) | 225 (30.7) | 71 (9.7) | 733 (100) |
| 5.57 (7.07) | 7.18 (9.52) | 7.46 (7.84) | 5.9 (7.5) | |
| 7.52 (1.81) | 13.07 (1.05) | 17.16 (1.26) | 8.6 (3.0) | |
| 216 (61.2) | 98 (27.8) | 39 (11.0) | 353 (100) | |
| 2.06 | 4.27 | 7.42 | 2.61 |
Summary of ROC Analyses for Each Medical Speciality
| Speciality | Fallers (n) | Non-Fallers (n) | p-value | AUCa, (95% CIb) | Cut-Point 9 | Cut-Point 12 | Cut-Point 16 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Sensitivity | Specificity | Sensitivity | Specificity | Sensitivity | Specificity | |||||
| Medical | 77 | 10,531 | <0.01 | 0.67 (0.61–0.73) | 0.753 | 0.565 | 0.299 | 0.818 | 0.104 | 0.971 |
| Surgical | 21 | 4002 | 0.06 | 0.62 (0.49–0.76) | 0.571 | 0.622 | 0.333 | 0.848 | 0.143 | 0.972 |
| Obstetrics and gynaecology, NAc | 2 | 603 | 0.81 | |||||||
| Ophthalmology and otolaryngology, NAc | 1 | 563 | 0.22 | |||||||
| Oncology | 12 | 1221 | 0.04 | 0.67 (0.48–0.86) | 0.583 | 0.745 | 0.333 | 0.929 | 0.083 | 0.987 |
| Neurology | 36 | 4986 | <0.01 | 0.67 (0.60–0.75) | 0.750 | 0.573 | 0.278 | 0.816 | 0.028 | 0.960 |
| General medicine | 3 | 349 | 0.06 | 0.82 (0.55–1.00) | ||||||
| Somatic | 152 | 22,255 | <0.01 | 0.668 (0.63–0.71) | 0.711 | 0.594 | 0.303 | 0.831 | 0.099 | 0.970 |
Notes: aThe area under the ROC curve, bconfidence interval, cno answers.
Poisson Regression Results and Falls per 1000/Hospital Days by the Risk Levels of the PHFRAT in Somatic Data (Obstetrics and Gynecology/Ophthalmology and Otolaryngology Data Were Not Analyzed Due to Incomplete Data)
| Speciality (n = patients) | Risk Level | Falls (n = 152) | LOSa Sum | Falls 1000/ Hospital Days | RRb (95% CIc) |
|---|---|---|---|---|---|
| Medical (10,608) | High Risk | 8 | 2060 | 3,9 | 3.71 (1,77–7,80) |
| Medium Risk | 15 | 10,705 | 1,4 | 1.34 (0.76–2.37) | |
| Low Risk | 54 | 51,588 | 1,0 | (reference) | |
| Surgical (4023) | High Risk | 3 | 725 | 4,1 | 4.69 (1.35–16.32) |
| Medium Risk | 4 | 2839 | 1,4 | 1.60 (0.53–4.85) | |
| Low Risk | 14 | 15,858 | 0,9 | (reference) | |
| Oncology (1233) | High Risk | 1 | 116 | 8,6 | 5.29 (0.66–42.28) |
| Medium Risk | 3 | 442 | 6,8 | 4.15 (1.10–15.65) | |
| Low Risk | 8 | 4898 | 1,6 | (reference) | |
| Neurology (5022) | High Risk | 1 | 1743 | 0,6 | 0.49 (0.07–3.59) |
| Medium Risk | 9 | 5356 | 1,7 | 1.43 (0.67–3.05) | |
| Low Risk | 26 | 22,083 | 1,2 | (reference) | |
| General medicine (352) | High Risk | 2 | 157 | 12,7 | 8.48 (0.77–9.55) |
| Medium Risk | 0 | 699 | 0,0 | ||
| Low Risk | 1 | 666 | 1,5 | (reference) | |
| Somatic (22,407) | High Risk | 15 | 4816 | 3,1 | 2.88 (1.68–4.94) |
| Medium Risk | 31 | 20,267 | 1,5 | 1.41 (0.95–2.11) | |
| Low Risk | 106 | 97,976 | 1,1 | (reference) |
Notes: aLength of stay, days; brealtive risk; cconfidence interval.
Poisson Regression Results and Falls per 1000/Hospital Days by Risk Factors of the PHFRAT in Somatic Data n=22,407
| PHFRAT Risk Factors | Parameter | Falls (n = 155) | LOSa Sum | Falls 1000/ Hospital Days | RRb (95%, CIc) |
|---|---|---|---|---|---|
| Recent falls | > 1 in last 3 months | 45 | 36,261 | 1.2 | 1.775 (1.02–3.11) |
| One in last 3 months | 18 | 6854 | 2.6 | 2.125 (1.23–3.67) | |
| One or more last 12 months | 17 | 7599 | 2.2 | 1.084 (0.74–1.60) | |
| None in last 12 months | 75 | 82,210 | 0.9 | (reference) | |
| Medications | Taking more than two | 32 | 32,253 | 1.0 | 1.227 (0.71–2.11) |
| Taking two | 56 | 43,503 | 1.3 | 1.429 (0.83–2.46) | |
| Taking one | 48 | 33,922 | 1.4 | 1.115 (0.63–1.97) | |
| Not taking any of these | 19 | 23,245 | 0.8 | (reference) | |
| Psychological | Appears severely affected by one or more | 48 | 36,085 | 1.3 | 2.044 (1.05–3.98) |
| Appears moderately affected by one or more | 18 | 10,911 | 1.6 | 1.929 (1.14–3.26) | |
| Appears mildly affected by one or more | 38 | 20,992 | 1.8 | 1.549 (1.01–2.37) | |
| Does not appear to have any of these | 51 | 64,935 | 0.8 | (reference) | |
| Cognitive status | Severely impaired | 7 | 5141 | 1.7 | 0.874 (0.37–2.05) |
| Mod impaired | 17 | 9205 | 1.8 | 1.084 (0.59–2.0) | |
| Mildly impaired | 43 | 24056 | 1.8 | 1.157 (0.75–1.78) | |
| Intact | 88 | 94520 | 0.9 | (reference) |
Notes: aLength of stay; brelative risk; cconfidence interval.
The Characteristics of the Study Patients and Results of the PHFRATa by Medical Specialties
| Medical Specialty | Medical (n = 150) | Surgical (n = 84) | Neurology (n = 92) | Psychogeriatry (n = 33) | Total n = 359 |
|---|---|---|---|---|---|
| Gender n (%) | |||||
| Male | 80 (53.3) | 32 (38.1) | 41 (44.6) | 8 (24.2) | 161 (44.8) |
| Female | 70 (46.7) | 52 (61.9) | 51 (55.4) | 25 (75.8) | 198 (55.2) |
| Age, mean (± SDb) | 70.1(13.4) | 69.2 (13.4) | 62.5 (16.6) | 76.1 (6.0) | 68,8 (14.7) |
| LOSc, Mean (± SDb) | 6.7 (6.4) | 5.8 (6.6) | 6.4 (4.5) | 42.7 (34.5) | 9.7 (15.8) |
| PHFRATa Scores, mean (± SDb) | 8.7 (2.7) | 8.5 (2.5) | 8.3 (2.6) | 10.5 (2.1) | 8.7 (2.6) |
| Risk level of the PHFRATa n (%) | |||||
| Low risk | 124 (82.7) | 75 (89.3) | 81 (88.0) | 22 (66.7) | 302 (84.1) |
| Medium risk | 23 (15.3) | 8 (9.5) | 10 (10.9) | 11 (33.3) | 52 (14.5) |
| High risk | 3 (2.0) | 1 (1.2) | 1 (1.1) | 0 | 5 (1.4) |
Notes: aThe Peninsula Health Fall Risk Assessment Tool; bstandard deviation; clength of stay.
Inter-Rater Reliability Coefficients by Fleiss’ Kappa for the PHFRATa in the All Data and Specialties
| Specialties (n) | PHFRATa Risk Factors | Fleiss’ Kappa | 95% CIb |
|---|---|---|---|
| Neurological (91) | Recent falls | 0.76 | 0.54–0.88 |
| Medications | 0.60 | 0.49–0.72 | |
| Psychological | 0.56 | 0.40–0.71 | |
| Cognitive status | 0.61 | 0.45–0.77 | |
| Risk level | 0.65 | 0.46–0.84 | |
| Medical (155) | Recent falls | 0.61 | 0.50–0.72 |
| Medications | 0.46 | 0.37–0.56 | |
| Psychological | 0.39 | 0.27–0.51 | |
| Cognitive status | 0.47 | 0.34–0.60 | |
| Risk level | 0.60 | 0.45–0.74 | |
| Psycho-geriatric (35) | Recent falls | 0.84 | 0.58–1.10 |
| Medications | 0.93 | 0.68–1.84 | |
| Psychological | 0.80 | 0.61–1.00 | |
| Cognitive status | 0.94 | 0.62–1.25 | |
| Risk level | 1.00 | 0.67–1.33 | |
| Surgical (78) | Recent falls | 0.60 | 0.45–076 |
| Medications | 0.72 | 0.59–0.85 | |
| Psychological | 0.54 | 0.35–0.72 | |
| Cognitive status | 0.62 | 0.43–0.82 | |
| Risk level | 0.55 | 0.34–0.75 | |
| All participants (359) | Recent falls | 0.66 | 0.58–0.73 |
| Medications | 0.60 | 0.54–0.66 | |
| Psychological | 0.56 | 0.48–0.63 | |
| Cognitive status | 0.60 | 0.51–0.68 | |
| Risk level | 0.68 | 0.58–0.77 |
Notes: aThe Peninsula Health Fall Risk Assessment Tool; bconfidence interval.